Psomagen, Inc. Logo

Psomagen, Inc.

A CRO providing multiomics services & data analysis for academic, biotech, and pharma researchers.

950200 | KO

Overview

Corporate Details

ISIN(s):
KR8840150005
LEI:
Country:
United States of America
Address:
City of Wilmington, County of New Castle, State of Delaware, Corporation Trust Cen, Wilmington
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Psomagen, Inc. is a contract research organization (CRO) providing comprehensive multiomics services and data analysis to scientists, clinicians, and researchers in the academic, biotechnology, and pharmaceutical sectors. Formerly Macrogen USA, the company offers a full suite of services, including genomics, epigenomics, proteomics, transcriptomics, and bioinformatics. It leverages cutting-edge technologies such as Next-Generation Sequencing (NGS), Third-Generation Sequencing, spatial biology, and cell line authentication. Psomagen operates multiple CLIA-certified and CAP-accredited laboratories across the United States, emphasizing data quality, security, and a collaborative client service model to make advanced biological analysis both accessible and affordable.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.7 MB
2025-08-13 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 10.2 KB
2025-06-13 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.7 MB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 25.7 KB
2025-03-31 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 11.6 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 28.6 KB
2025-03-21 00:00
Annual Report
사업보고서 (2024.12)
Korean 2.2 MB
2025-03-21 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 346.5 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 14.2 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 209.4 KB
2025-02-14 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 12.8 KB
2025-01-17 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 15.7 KB
2025-01-03 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 105.3 KB
2025-01-03 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.1 KB

Automate Your Workflow. Get a real-time feed of all Psomagen, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Psomagen, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Psomagen, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

VALIRX PLC Logo
Advancing oncology & women's health therapeutics and offering preclinical research services.
United Kingdom
VAL
VALUE GOLF Inc. Logo
A golf services hub offering reservations, solo player bookings, e-commerce, lessons, and tours.
Japan
3931
Value HR Co., Ltd. Logo
Offers a health management platform and consulting for corporate health insurance societies in Japan.
Japan
6078
Global OTA for curated tours & experiences, focusing on travel to and from Japan.
Japan
7048
A South Korean travel company offering global tour packages, flights, hotels, and corporate travel.
South Korea
094850
Virax Biolabs Group Ltd Logo
Specializes in T-cell immunity tests and diagnostics for profiling viral disease responses.
United States of America
VRAX
VisionSys AI Inc Logo
Develops AI-powered brain-computer interfaces for the healthcare and biotech sectors.
United States of America
VSA
Vivesto Logo
Develops and licenses novel cancer therapies for humans and animals using proprietary drug delivery.
Sweden
VIVE
Vor Biopharma Inc. Logo
Clinical-stage biotech developing next-gen medicines that target the root cause of autoimmune disease.
United States of America
VOR
Voronoi, Inc. Logo
Develops selective kinase inhibitors and targeted protein degraders for precision oncology.
South Korea
310210

Talk to a Data Expert

Have a question? We'll get back to you promptly.